CLINICAL AND RADIOLOGICAL PICTURES OF HEPATOCELLULAR-CARCINOMA WITH INTRACRANIAL METASTASIS

被引:31
|
作者
YEN, FS
WU, JC
LAI, CR
SHENG, WY
KUO, BIT
CHEN, TZ
TSAY, SH
LEE, SD
机构
[1] VET GEN HOSP, NATL YANG MING MED COLL, DEPT MED & PATHOL, DIV GASTROENTEROL, TAIPEI, TAIWAN
[2] TAO YUAN VET HOSP, DIV MED, TAYUAN, TAIWAN
关键词
HEPATOCELLULAR CARCINOMA; INTRACRANIAL METASTASIS;
D O I
10.1111/j.1440-1746.1995.tb01593.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) with extrahepatic spreading is not uncommon. In order to delineate the clinical and radiological pictures of HCC with intracranial metastasis, 33 documented cases were analysed. Eighteen had brain parenchymal metastasis without skull involvement; the other 15 cases disclosed skull metastasis with brain invasion. The underlying HCC are mainly of expanding (13/33, 39.4%) and multifocal (13/33, 39.4%) types. Eighteen cases (18/33, 54.5%) had mental changes not related to hypoglycaemia or hepatic encephalopathy. Eighteen cases (18/20, 90%) disclosed hyperdense mass lesions by non-contrast computed tomography (CT) scans and 17 cases showed homogeneous enhancement (17/22, 77.3%) by post-contrast CT images. In the non-skull involved group, five cases (5/12, 41.7%) disclosed ring-shape enhancement and 14 cases (14/16, 87.5%) had perifocal oedema, which were not seen in the skull involved group. Eight cases (8/33, 24.2%) presented as intracerebral haemorrhage. Twelve (12/33, 36.4%) died of brain herniation. Most (14/18, 77.8%) non-skull involved cases had simultaneous lung metastasis without bony metastasis, while the skull involved group often (10/15, 66.7%) disclosed extracranial bony metastasis without lung metastasis. The difference in extracranial metastasis was statistically significant (P < 0.05). The multivariate survival analysis disclosed that lower lactate dehydrogenase level (less than or equal to 316 Un, P = 0.029) and treatments (surgery or radiation, P = 0.001) were positively associated with longer survival. In conclusion, HCC with intracranial metastasis is symptomatic and life-threatening. Half the cases may come from pulmonary metastasis and the other half may be from bony metastasis. Brain irradiation or surgery can prolong their survival.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 50 条
  • [41] HEPATOCELLULAR-CARCINOMA
    SKEGG, DCG
    NEW ZEALAND MEDICAL JOURNAL, 1983, 96 (741) : 775 - 776
  • [42] THE HEPATOCELLULAR-CARCINOMA
    LAUCHART, W
    ZENTRALBLATT FUR CHIRURGIE, 1994, 119 (11): : 751 - 752
  • [43] HEPATOCELLULAR-CARCINOMA
    COLOMBO, M
    JOURNAL OF HEPATOLOGY, 1992, 15 (1-2) : 225 - 236
  • [44] HEPATOCELLULAR-CARCINOMA
    WOODFIELD, DG
    NEW ZEALAND MEDICAL JOURNAL, 1986, 99 (795) : 69 - 69
  • [45] HEPATOCELLULAR-CARCINOMA
    BENET, AA
    CARRASCO, TA
    VALLS, MS
    MASIP, JP
    GOU, JC
    MEDICINA CLINICA, 1984, 82 (15): : 693 - 693
  • [46] HEPATOCELLULAR-CARCINOMA
    DIBISCEGLIE, AM
    RUSTGI, VK
    HOOFNAGLE, JH
    DUSHEIKO, GM
    LOTZE, MT
    ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) : 390 - 401
  • [47] HEPATOCELLULAR-CARCINOMA
    WEINSTEIN, SC
    SOUTH AFRICAN JOURNAL OF SURGERY, 1984, 22 (02) : 113 - 114
  • [48] EPIRUBICIN IN HEPATOCELLULAR-CARCINOMA - PHARMACOKINETICS AND CLINICAL ACTIVITY
    DOBBS, NA
    TWELVES, CJ
    RIZZI, P
    WARWICK, JD
    METIVIER, EM
    WILLIAMS, R
    JOHNSON, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (05) : 405 - 410
  • [49] HEPATOCELLULAR-CARCINOMA
    HABSCHEID, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (49) : 1926 - 1931
  • [50] HEPATOCELLULAR-CARCINOMA
    PROPST, A
    PROPST, T
    WALDENBERGER, P
    JUDMAIER, G
    VOGEL, W
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 125 (44) : 2137 - 2142